Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy

被引：0
|
作者：
Keisuke Enomoto
Hidenori Inohara
Ichiro Higuchi
Kenichiro Hamada
Yoichiro Tomiyama
Takeshi Kubo
Jun Hatazawa
机构：
[1] Osaka University School of Medicine,Department of Otolaryngology
[2] Osaka University School of Medicine,Department of Nuclear Medicine and Tracer Kinetics
来源：
Molecular Imaging and Biology | 2008年 / 10卷
关键词：
FDG; PET; HNSCC; Oropharynx; Carcinoma; Prognosis; Chemoradiotherapy; Neck;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] FDG-PET predicts outcome in nasopharyngeal carcinoma treated patients
    Lee, Jong-Kang
    Liu, Wen-Shan
    Weng, Jui-Hung
    Li, Yueh-Chun
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [22] Concurrent chemoradiotherapy for oropharyngeal carcinoma
    Kokubo, M
    Nagata, Y
    Nishimura, Y
    Kimura, H
    Shoji, K
    Asato, R
    Sasai, K
    Hiraoka, M
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (01): : 71 - 76
  • [23] Prognostic value of FDG PET/CT in patients with hepatocellular carcinoma treated with liver transplantation
    Govaerts, L.
    Detry, O.
    Bletard, N.
    Verset, G.
    Honore, P.
    De Roover, A.
    Delwaide, J.
    Hustinx, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S287 - S287
  • [24] Recurrent germinal tumor carcinoma: clinical and prognostic value of FDG-PET/TC
    Alongi, P.
    Picchio, M.
    Caobelli, F.
    Spallino, M.
    Gianolli, L.
    Midiri, M.
    Evangelista, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S412 - S413
  • [25] Diagnostic and prognostic value of FDG-PET/CT in recurrent germinal tumor carcinoma
    Alongi, Pierpaolo
    Picchio, Maria
    Spallino, Marianna
    Gianolli, Luigi
    Evangelista, Laura
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [26] Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy
    Erkan Topkan
    Cem Parlak
    Ayşe Kotek
    Ali Fuat Yapar
    Berrin Pehlivan
    BMC Gastroenterology, 11
  • [27] Improving The Prognostic Value Of FDG-PET For NSCLC Patients Treated With SABR Using Advanced Computational Modeling
    Li, R.
    Aguilera, T. A.
    Shultz, D. B.
    Rubin, D.
    Diehn, M.
    Loo, B. W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S7 - S7
  • [28] Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy
    Topkan, Erkan
    Parlak, Cem
    Kotek, Ayse
    Yapar, Ali Fuat
    Pehlivan, Berrin
    BMC GASTROENTEROLOGY, 2011, 11
  • [29] The value of FDG-PET in recurrent testicular carcinoma
    Hain, S
    O'Doherty, M
    Leslie, M
    Timothy, A
    Harper, PG
    Huddart, RA
    BRITISH JOURNAL OF CANCER, 1999, 80 : 109 - 109
  • [30] Prognostic Value of FDG-PET Metrics for Advanced NSCLC Patients Treated with First-line Immunotherapy
    Andraos, T. Y.
    Halmos, B.
    Cheng, H.
    Huntzinger, C.
    Ohri, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E116 - E117
12345